Cancer Investigation, Volume 34, Issue 10 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Cancer Investigation, Volume 34, Issue 10 (2016)

See all volumes and issues
Vol 42, 2024 Vol 41, 2023 Vol 40, 2022 Vol 39, 2021 Vol 38, 2020 Vol 37, 2019 Vol 36, 2018 Vol 35, 2017 Volume 34, 2016 Vol 33, 2015 Vol 32, 2014 Vol 31, 2013 Vol 30, 2012 Vol 29, 2011 Vol 28, 2010 Vol 27, 2009 Vol 28, 2010 Vol 27, 2009 Vol 26, 2008 Vol 25, 2007 Vol 24, 2006 Vol 23, 2005 Vol 22, 2004 Vol 21, 2003 Vol 20, 2002 Vol 19, 2001 Vol 18, 2000 Vol 17, 1999 Vol 16, 1998 Vol 15, 1997 Vol 14, 1996 Vol 13, 1995 Vol 12, 1994 Vol 11, 1993 Vol 10, 1992 Vol 9, 1991 Vol 8, 1990 Vol 7, 1989 Vol 6, 1988 Vol 5, 1987 Vol 4, 1986 Vol 3, 1985 Vol 2, 1984 Vol 1, 1983
Download citations Download PDFs Download issue

Original Articles

Article
S100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion
Hongfei Jiang, Hang Hu, Fan Lin, Yoon Pin Lim, Yunfen Hua, Xiaomei Tong & Songying Zhang
Pages: 477-488
Published online: 24 Oct 2016
AbstractforS100P is Overexpressed in Squamous Cell and Adenosquamous Carcinoma Subtypes of Endometrial Cancer and Promotes Cancer Cell Proliferation and Invasion | Full Text | References | PDF (914.2 KB)
  • 216 Views
  • 8 CrossRef citations
  • 0Altmetric

Reports

Report
Deferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells
George A. Alexiou, Paraskevi Gerogianni, Evrysthenis Vartholomatos & Athanasios P. Kyritsis
Pages: 489-495
Published online: 21 Oct 2016
AbstractforDeferiprone Enhances Temozolomide Cytotoxicity in Glioma Cells | Full Text | References | PDF (791.5 KB)
  • 203 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Articles

Article
4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways
Yun Liang, Xin He, Xian Li, Xuzhao Zhang, Xiaohong Zhang, Lei Zhang, Xi Qiu, Xiaoying Zhao & Rongzhen Xu
Pages: 496-505
Published online: 21 Oct 2016
Abstractfor4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways | Full Text | References | PDF (848.1 KB)
  • 153 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma
Wei Liu, Zhiming Dong, Jia Liang, Xin Guo, Yanli Guo, Supeng Shen, Gang Kuang & Wei Guo
Pages: 506-516
Published online: 28 Oct 2016
AbstractforDownregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma | Full Text | References | PDF (868 KB) | Supplemental
  • 120 Views
  • 13 CrossRef citations
  • 0Altmetric

Brief Report

Report
Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer
Brian Y. Park, Rachel N. Grisham, Bjørnar den Hollander, Dharmarao Thapi, Tara Berman, Elisa de Stanchina, Qin Zhou, Gopa Iyer, Carol Aghajanian & David R. Spriggs
Pages: 517-520
Published online: 08 Nov 2016
AbstractforTumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer | Full Text | References | PDF (394 KB)
  • 268 Views
  • 11 CrossRef citations
  • 0Altmetric

Original Articles

Article
Attributable Risk of Infection to mTOR Inhibitors Everolimus and Temsirolimus in the Treatment of Cancer
Christine A. Garcia & Shenhong Wu
Pages: 521-530
Published online: 28 Oct 2016
AbstractforAttributable Risk of Infection to mTOR Inhibitors Everolimus and Temsirolimus in the Treatment of Cancer | Full Text | References | PDF (695.8 KB)
  • 424 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Do Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity?
Heidi Egloff & Aminah Jatoi
Pages: 531-535
Published online: 28 Oct 2016
AbstractforDo Ovarian Cancer Patients with a Family History of Cancer (Suspected BRCA1 or BRCA2 Mutation) Suffer Greater Chemotherapy Toxicity? | Full Text | References | PDF (299.5 KB)
  • 146 Views
  • 4 CrossRef citations
  • 0Altmetric

REVIEW

Review
Hypoxia: A Double-Edged Sword in Cancer Therapy
Hamed Manoochehri Khoshinani, Saeid Afshar & Rezvan Najafi
Pages: 536-545
Published online: 08 Nov 2016
AbstractforHypoxia: A Double-Edged Sword in Cancer Therapy | Full Text | References | PDF (557.3 KB)
  • 1887 Views
  • 111 CrossRef citations
  • 0Altmetric

Editorial Board

EOV Editorial Board
Page: ebi
Published online: 05 Dec 2016
CitationforEOV Editorial Board | Full Text | PDF (30.2 KB)
  • 7 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Barthel Index and Age as Predictors of Discharge Destination in Patients with Glioblastoma
Hirotomo Shibahashi et al.
Article | Published online: 27 Jun 2024
Open Access
The Impact of Prophylactic Post-Chemotherapy G-CSF on the Relapse Rates in Patients with Acute Myeloid Leukemia: A Meta-Analysis
Mohammadreza Bordbar et al.
Review Article | Published online: 26 Jun 2024
Fusobacterium Detected in Barrett’s Esophagus and Esophageal Adenocarcinoma Tissues
Tomomitsu Tahara et al.
Article | Published online: 24 Jun 2024
A Bioinformatic Analysis of Gut Microbiota Related with Immune Cell Infiltration in Colorectal Cancer
Dan Liu et al.
Article | Published online: 21 Jun 2024
Open Access
View all latest articles